GSK Spin-Off Affymax Generates $20M In Private Financing Round June 30, 2003 By Aaron Lorenzo Affymax Inc. closed a $20 million private round of financing that coincided with the drug discovery and development firm's appointment of a new chief executive. (BioWorld Today)Read More
Nektar Prices $100M In Notes As It Moves Programs Forward June 27, 2003 By Aaron Lorenzo Drug delivery firm Nektar Therapeutics priced its offering of $100 million in notes reported earlier this week.Read More
Nektar Prices $100M In Notes As It Moves Programs Forward June 27, 2003 By Aaron Lorenzo Drug delivery firm Nektar Therapeutics priced its offering of $100 million in notes reported earlier this week.Read More
